Literature DB >> 18418678

Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings.

Ludger Schöls1, Christoph Linnemann, Christoph Globas.   

Abstract

Spinocerebellar ataxias (SCAs) comprise a clinically and genetically heterogeneous group of autosomal dominantly inherited neurodegenerative disorders affecting the cerebellum and to variable degrees further parts of the nervous system. Electrophysiology is a potent tool to prove impairment of multiple neuronal systems and fibre tracts and even to decipher subclinical affection. Electrooculography, evoked potentials, nerve conduction studies and polysomnography are especially helpful in the setting of SCAs. Severely slowed saccades are a hallmark of SCA2. Vertical nystagmus occurs most frequently in SCA3 and SCA6. Visual potentials recede especially in SCA7. Substantially prolonged central motor conduction times in motor-evoked potentials occur frequently in SCA1 even in patients without clinical signs of pyramidal affection. Thus, electrophysiological analyses may help to predict the SCA genotype and direct molecular genetic diagnostics. Polysomnography is a helpful tool in the analysis of sleep disorders and frequently helps to decipher treatable causes like periodic leg movement in sleep and REM sleep behaviour disorder in SCAs. Nerve conduction studies reveal sensory neuropathy in all common SCA subtypes, but to variable degrees. Age rather than CAG repeat length appears to be the most important determinant for neuropathy and makes sensory nerve action potentials a potential progression marker in SCA.

Entities:  

Mesh:

Year:  2008        PMID: 18418678     DOI: 10.1007/s12311-008-0024-1

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  31 in total

1.  Motor evoked potentials in the spinocerebellar ataxias type 1 and type 3.

Authors:  L Schöls; G Amoiridis; M Langkafel; S Schöls; H Przuntek
Journal:  Muscle Nerve       Date:  1997-02       Impact factor: 3.217

2.  Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect.

Authors:  Peter Schwenkreis; Martin Tegenthoff; Katja Witscher; Christian Börnke; Horst Przuntek; Jean-Pierre Malin; Ludger Schöls
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

3.  Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7.

Authors:  A K Oh; K M Jacobson; J C Jen; R W Baloh
Journal:  Ann Neurol       Date:  2001-06       Impact factor: 10.422

4.  Classification of the hereditary ataxias and paraplegias.

Authors:  A E Harding
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

5.  Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2.

Authors:  Sylvia M Boesch; Birgit Frauscher; Elisabeth Brandauer; Gregor K Wenning; Birgit Högl; Werner Poewe
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

6.  Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32.

Authors:  Zoran Brkanac; Magali Fernandez; Mark Matsushita; Hilary Lipe; John Wolff; Thomas D Bird; Wendy H Raskind
Journal:  Am J Med Genet       Date:  2002-05-08

7.  Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds.

Authors:  L Schöls; R Krüger; G Amoiridis; H Przuntek; J T Epplen; O Riess
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

8.  Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1.

Authors:  K Flanigan; K Gardner; K Alderson; B Galster; B Otterud; M F Leppert; C Kaplan; L J Ptácek
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

9.  Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?

Authors:  L Schöls; J Haan; O Riess; G Amoiridis; H Przuntek
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

10.  Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.

Authors:  A Dürr; G Stevanin; G Cancel; C Duyckaerts; N Abbas; O Didierjean; H Chneiweiss; A Benomar; O Lyon-Caen; J Julien; M Serdaru; C Penet; Y Agid; A Brice
Journal:  Ann Neurol       Date:  1996-04       Impact factor: 10.422

View more
  12 in total

1.  An electrophysiological study of visual processing in spinocerebellar ataxia type 2 (SCA2).

Authors:  Jan Kremlacek; Martin Valis; Jiri Masopust; Ales Urban; Alena Zumrova; Radomir Talab; Miroslav Kuba; Zuzana Kubova; Jana Langrova
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

2.  Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; André Carvalho Felício; Lívia Almeida Dutra; William A C Santos; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

Review 3.  Consensus Paper: Neurophysiological Assessments of Ataxias in Daily Practice.

Authors:  W Ilg; M Branscheidt; A Butala; P Celnik; L de Paola; F B Horak; L Schöls; H A G Teive; A P Vogel; D S Zee; D Timmann
Journal:  Cerebellum       Date:  2018-10       Impact factor: 3.847

4.  Functional consequences of oculomotor disorders in hereditary cerebellar ataxias.

Authors:  M F Alexandre; S Rivaud-Péchoux; G Challe; A Durr; B Gaymard
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

5.  A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7.

Authors:  L Velázquez-Pérez; C M Cerecedo-Zapata; O Hernández-Hernández; E Martínez-Cruz; Y S Tapia-Guerrero; R González-Piña; J Salas-Vargas; R Rodríguez-Labrada; R Gurrola-Betancourth; N Leyva-García; B Cisneros; J J Magaña
Journal:  Neurogenetics       Date:  2014-10-16       Impact factor: 2.660

6.  Progress of macular atrophy during 30 months' follow-up in a patient with spinocerebellar ataxia type1 (SCA1).

Authors:  Ayane Hirose; Satoshi Katagiri; Takaaki Hayashi; Tomokazu Matsuura; Norihiro Nagai; Kaoru Fujinami; Takeshi Iwata; Kazushige Tsunoda
Journal:  Doc Ophthalmol       Date:  2020-07-09       Impact factor: 2.379

7.  Retinal Nerve Fibre Layer and Macular Thinning in Spinocerebellar Ataxia and Cerebellar Multisystem Atrophy.

Authors:  John H Pula; Vernon L Towle; Victoria M Staszak; Dingcai Cao; Jacqueline T Bernard; Christopher M Gomez
Journal:  Neuroophthalmology       Date:  2011-06

Review 8.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

9.  Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment.

Authors:  Marcio Luiz Escorcio Bezerra; José Luiz Pedroso; Pedro Braga-Neto; Agessandro Abrahao; Marcus Vinicius Cristino de Albuquerque; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Nadia Iandoli de Oliveira Braga; Gilberto Mastrocola Manzano; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

10.  Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Sarah Doss; Alexander U Brandt; Timm Oberwahrenbrock; Matthias Endres; Friedemann Paul; Jan Leo Rinnenthal
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.